Biomarker Technologies Market, by Product (Consumables, Assays, Reagents, Instruments), Profiling Technology (Immunoassay, PCR, Imaging Technologies, Mass Spectrometry, NGS, Chromatography, Cytogenetics, Other), Application (Drug Discovery, Diagnostics, Personalized Medicine), Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, Others), Research Area (Genomics, Proteomics, Others), Region (North America, Europe, Asia Pacific, Middle East and Africa, South America)– Market Size & Forecasting To 2030

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

The Biomarker Technologies Market is valued at USD 32,600.71 million in 2021 is expected to grow at a CAGR of 11.3% during the forecast period. A biomarker is a biobased molecule which is found in the tissues and body fluids which sheds light on the normal as well as abnormal functions or diseases. These biomarkers can diagnose the disease at the initial stage and are widely used in diagnosis of cancer and its treatment. Increasing research and development activities in the healthcare sector, the rising trend of biomarkers cancer treatment, and growing trials for biomarkers are expected to drive market growth.

Technological advancement and discovery are expected to augment market growth. Moreover, various governments have taken initiatives for controlling cancer, cardiovascular and neurological disorders, and diabetes, contributing to market growth. Increasing investments in research and development by the pharma and biotechnology industries are fueling market growth. Apart from this the development in the healthcare technologies in many developing countries are increasing the demand for the market. The rising number of geriatric people across the world and increasing disposable income of people demanding efficient healthcare services are also expected to accelerate the global biomarker technologies market growth.

Furthermore, the lesser cost needed for conducting clinical trials in the developing economies becomes attractive for the multinational companies to invest more in the clinical trials. However, the low capita income and poor healthcare infrastructure in developing regions are major factors that can hamper the global biomarker technologies market growth.

TABLE 1: GLOBAL BIOMARKER TECHNOLOGIES MARKET OVERALL SNAPSHOT

TABLE 1: GLOBAL BIOMARKER TECHNOLOGIES MARKET OVERALL SNAPSHOT

Market Segmentation

The global biomarker technologies market is segmented into product, profiling technology, application, indication, research and region.

FIGURE 2: GLOBAL BIOMARKER TECHNOLOGIES MARKET SEGMENTATION

FIGURE 2: GLOBAL BIOMARKER TECHNOLOGIES MARKET SEGMENTATION

Global Biomarker Technologies Market, by Product

Based on product, the global biomarker technologies market is segmented into consumables, assays, reagents and instruments. Among these, the consumables segment is expected to be the largest segment during the forecast period owing to its larger sales volume of the product which will ultimately increase the profit.

Global Biomarker Technologies Market, by Profiling Technology

Based on the profiling technology, the global biomarker technologies market is segmented into immunoassay, PCR, imaging technologies, mass spectrometry, NGS, chromatography, cytogenetics and other. The immunoassay segment is further classified into ELISA, western blot, protein microarray. Immunoassay is expected to be the largest segment during the forecast period. ELISA, a technology used in immunoassay, simultaneously quantifies protein level and also has the capacity in accelerating the process of biomarker protein validation for clinical usage. This factor is expected to drive the segment growth.

Global Biomarker Technologies Market, by Application

Based on the application, the global biomarker technologies market is segmented into drug discovery, diagnostics, and personalized medicine. Among these, drug discovery is expected to be the largest segment during the forecast period. The segment growth can be owing to increasing use of biomarkers in the drug discovery of various types of health issues and diseases such as cardiovascular problems, cancer, neurological problems and others.

Global Biomarker Technologies Market, by Indication

Based on indication, the global biomarker technologies market is segmented into cancer, infectious diseases, autoimmune disorders, cardiovascular disorders and others. The infectious diseases segment is expected to be the fastest growing segment owing to its increasing use in infectious diseases including distinguishing bacterial from non-bacterial infection, analyzing the response to therapy, and predicting outcomes.

Global Biomarker Technologies Market, by Research Area

Based on the research area, the global biomarker technologies market is segmented into genomics, proteomics, others. The proteomics segment is further classified into metabolomics, metabolic flux, lipidomics. Among these, genomics is expected to be the largest segment during the forecast period as it can diagnose genetic disease by reducing genetic testing to a single analysis.

Global Biomarker Technologies Market, by Region

Based on region, the global biomarker technologies market is segmented into North America, Europe, Asia Pacific, the Middle East and South America. North America is expected to hold the highest market share during the forecast period. The regional market growth is due to increasing incidences of cardiovascular diseases, cancer, autoimmune diseases and neurological disorders. Increasing elderly population and escalating healthcare expenses will further boost the regional market growth during the forecast period.

Europe is expected to observe significant market growth during the forecast period owing to availability of development treatment amenities and the well-settled healthcare infrastructure. Furthermore, the rising demand for effective and precise diagnosis and the increasing prevalence of cancer is expected to propel the regional market during the forecast period.

TABLE 2: GLOBAL BIOMARKER TECHNOLOGIES MARKET OVERVIEW

 

TABLE 2: GLOBAL BIOMARKER TECHNOLOGIES MARKET OVERVIEW

FIGURE 3: GLOBAL BIOMARKER TECHNOLOGIES MARKET (USD MILLION), 2021-2030

FIGURE 3: GLOBAL BIOMARKER TECHNOLOGIES MARKET (USD MILLION), 2021-2030

Recent Developments in the Global Biomarker Technologies Market

  • May 2021- QIAGEN N.V. joined hands with Mirati Therapeutics to foster KRAS G12C buddy indicative for the non-small cell lung cancer. The new buddy symptomatic will grow QIAGEN’S therascreen KRAS testing portfolio.
  • November 2020- QIAGEN N.V. collaborated with BioNTech to create and marketing a tissue-based buddy analytic which is to be used with investigational malignant growth treatment BNT113.
  • July 2020- Thermo Fisher Scientific Inc. collaborated with Newomics which is the leading provider of microfluidic producers for fluid chromatography-mass spectrometry applications to streamline powerful LC-MS work processes for the approval of illness biomarkers.

What Does This Report Provide?

This report provides a detailed understanding of the global biomarker technologies market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market. The major market drivers, challenges, and opportunities for the global biomarker technologies market have been covered in the report. This report further includes the market shares of the leading companies operating in the global market, along with their production capacities and the growth strategies adopted by them.

Market Segmentation:

By Product

  • Consumables
  • Assay
  • Reagent
  • Instruments

By Profiling Technology

  • Immunoassay
    • ELISA
    • Western Blot
    • Protein Microarray
  • PCR
  • Imaging Technologies
  • Mass Spectrometry
  • NGS
  • Chromatography
  • Cytogenetics
  • Other Profiling Technologies

By Application

  • Drug Discovery
  • Diagnostics
  • Personalized Medicine

By Indication

  • Cancer
  • Infectious Diseases
  • Autoimmune Disorders
  • Cardiovascular Disorders
  • Others

By Research Area

  • Genomics
  • Proteomics
    • Metabolomics
    • Metabolic Flux
    • Lipidomics
  • Others
  • Other Research Areas

By Region:

North America Biomarker Technologies Market

  • North America, by Country
    • US.
    • Canada
    • Mexico
  • North America, by Product
  • North America, by Profiling Technology
  • North America, by Application
  • North America, by Indication
  • North America, by Research Area

Europe Biomarker Technologies Market

  • Europe, by Country
    • Germany
    • UK.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Europe, by Product
  • Europe, by Profiling Technology
  • Europe, by Application
  • Europe, by Indication
  • Europe, by Research Area

Asia Pacific Biomarker Technologies Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Asia Pacific, by Product
  • Asia Pacific, by Profiling Technologies
  • Asia Pacific, by Application
  • Asia Pacific, by Indication
  • Asia Pacific, by Research Area

Middle East and Africa Biomarker Technologies Market

  • Middle East and Africa, by Country
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East and Africa
  • Middle East and Africa, by Product
  • Middle East and Africa, by Profiling Technology
  • Middle East and Africa, by Application
  • Middle East and Africa, by Indication
  • Middle East and Africa, by Research Area

South America Biomarker Technologies Market

  • South America, by Country
    • Brazil
    • Argentina
    • Rest of South America
  • Rest of South America, by Product
  • Rest of South America, by Profiling Technology
  • Rest of South America, by Application
  • Rest of South America, by Indication
  • Rest of South America, by Research Area

Major Companies: In this report, the major companies studied are: Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Illumina, Inc., LI-COR, Inc., Merck KGAA, PerkinElmer Inc., QIAGEN, Shimadzu Corporation, and Thermo Fisher Scientific, Inc.

Objectives of this Report:

  • To estimate the market size for the biomarker technologies market on a regional and global basis
  • To identify major segments in the biomarker technologies market and evaluate their market shares and demand
  • To provide a competitive scenario for the market with major developments observed by the key companies in the historic years
  • To evaluate the key factors governing the dynamics of the corporate market with their potential gravity during the forecast period
  • To evaluate the leading company-wise pricing analysis for the mentioned applications

Key Questioned Answered in the Study:

  • What are major growth drivers and market trends that are impacting the global biomarker technologies market?
  • What is the market size both in terms of value and volume for the global biomarker technologies market?
  • Who are the leading market players and who are the new market players that operate in the global market with an estimated market share?
  • What are the future investment pockets and opportunities in the global biomarker technologies market?
  • Major list of customers and potential futuristic customer list along with an estimated buying volume
  • Impact of COVID-19 on the global biomarker technologies market

Customization:

This study is customized to meet your specific requirements:

  • By sub-segment
  • By client-specific country, type, and application market analysis
  • Pricing analysis along with the potential list of customers
  • Product-specific competitive analysis

For more information, contact: [email protected]